|
1
|
Coleman MP, Forman D, Bryant H, Butler J,
Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, et al;
ICBP Module 1 Working Group. Cancer survival in Australia, Canada,
Denmark, Norway, Sweden, and the UK, 1995–2007 (the International
Cancer Benchmarking Partnership): An analysis of population-based
cancer registry data. Lancet. 377:127–138. 2011. View Article : Google Scholar :
|
|
2
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bissell MJ and Radisky D: Putting tumours
in context. Nat Rev Cancer. 1:46–54. 2001. View Article : Google Scholar
|
|
4
|
Yan B, Kong M, Chen S and Chen YH: VEGF
stimulation enhances Livin protein synthesis through mTOR
signaling. J Cell Biochem. 111:1114–1124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Funahashi Y, Shawber CJ, Sharma A,
Kanamaru E, Choi YK and Kitajewski J: Notch modulates VEGF action
in endothelial cells by inducing Matrix Metalloprotease activity.
Vasc Cell. 3:22011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shan B, Li W, Yang SY and Li ZR: Estrogen
up-regulates MMP2/9 expression in endometrial epithelial cell via
VEGF-ERK1/2 pathway. Asian Pac J Trop Med. 6:826–830. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Enciso JM, Gratzinger D, Camenisch TD,
Canosa S, Pinter E and Madri JA: Elevated glucose inhibits
VEGF-A-mediated endocardial cushion formation: Modulation by
PECAM-1 and MMP-2. J Cell Biol. 160:605–615. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ebrahem Q, Chaurasia SS, Vasanji A, Qi JH,
Klenotic PA, Cutler A, Asosingh K, Erzurum S and Anand-Apte B:
Cross-talk between vascular endothelial growth factor and matrix
metalloproteinases in the induction of neovascularization in vivo.
Am J Pathol. 176:496–503. 2010. View Article : Google Scholar :
|
|
9
|
Ou JM, Ye B, Qiu MK, Dai YX, Dong Q, Shen
J, Dong P, Wang XF, Liu YB, Quan ZW, et al: Knockdown of Livin
inhibits growth and invasion of gastric cancer cells through
blockade of the MAPK pathway in vitro and in vivo. Int J Oncol.
44:276–284. 2014.
|
|
10
|
Lazar I, Perlman R, Lotem M, Peretz T,
Ben-Yehuda D and Kadouri L: The clinical effect of the inhibitor of
apopotosis protein livin in melanoma. Oncology. 82:197–204. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haferkamp A, Bedke J, Vetter C, Pritsch M,
Wagener N, Buse S, Crnkovic-Mertens I, Hoppe-Seyler K,
Macher-Goeppinger S, Hoppe-Seyler F, et al: High nuclear Livin
expression is a favourable prognostic indicator in renal cell
carcinoma. BJU Int. 102:1700–1706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun JG, Liao RX, Chen ZT, Wang ZX, Zhang
Q, Hu YD and Wang DL: Gene transfection of Livin isoforms into A549
cell line and its effect on cell growth and sensitivity to
chemotherapy and radiotherapy. Zhonghua Jie He He Hu Xi Za Zhi.
28:836–840. 2005.(In Chinese).
|
|
13
|
Lee DH, Yoon TM, Kim SA, Park YL, Lee KH,
Lim SC, Lee JK and Joo YE: Relationship between expression of Livin
and the biological behavior of human oral squamous cell carcinoma.
Oncol Rep. 32:2453–2460. 2014.PubMed/NCBI
|
|
14
|
Yoon TM, Kim SA, Lee DH, Lee JK, Park YL,
Lee KH, Chung IJ, Joo YE and Lim SC: Expression of Livin and the
inhibition of tumor progression by Livin silencing in
laryngohypopharyngeal cancer. In Vivo. 28:751–759. 2014.PubMed/NCBI
|
|
15
|
Li F, Yin X, Luo X, Li HY, Su X, Wang XY,
Chen L, Zheng K and Ren GS: Livin promotes progression of breast
cancer through induction of epithelial-mesenchymal transition and
activation of AKT signaling. Cell Signal. 25:1413–1422. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Fan S, Li L, Wang L, Fan G, Zhao Q
and Li Y: RNA interference-mediated knockdown of Livin suppresses
cell proliferation and invasion and enhances the chemosensitivity
to cisplatin in human osteosarcoma cells. Int J Oncol. 43:159–168.
2013.PubMed/NCBI
|
|
17
|
Chen F, Yang D, Che X, Wang J, Li X, Zhang
Z, Chen X and Song X: Livin mediates tumor cell invasion in the
DU-145 cell line via NF-κB. Oncol Rep. 27:2010–2016.
2012.PubMed/NCBI
|
|
18
|
Cho SB, Lee WS, Park YL, Kim N, Oh HH, Kim
MY, Oak CY, Chung CY, Park HC, Kim JS, et al: Livin is associated
with the invasive and oncogenic phenotypes of human hepatocellular
carcinoma cells. Hepatol Res. 45:448–457. 2015. View Article : Google Scholar
|
|
19
|
Myung DS, Park YL, Chung CY, Park HC, Kim
JS, Cho SB, Lee WS, Lee KH, Lee JH and Joo YE: Expression of Livin
in colorectal cancer and its relationship to tumor cell behavior
and prognosis. PLoS One. 8:e732622013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen YS, Li HR, Lin M, Chen G, Xie BS, Xu
NL and Lin LF: Livin abrogates apoptosis of SPC-A1 cell by
regulating JNKI signaling pathway. Mol Biol Rep. 37:2241–2247.
2010. View Article : Google Scholar
|
|
21
|
Chen YS, Li HR, Miao Y, Chen WY, Li YT,
Wang GQ and Wu ZC: Local injection of lentivirus-delivered livin
shRNA suppresses lung adenocarcinoma growth by inducing a G0/G1
phase cell cycle arrest. Int J Clin Exp Pathol. 5:796–805.
2012.
|
|
22
|
Liu B, Han M, Wen JK and Wang L:
Livin/ML-IAP as a new target for cancer treatment. Cancer Lett.
250:168–176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao X, Yuan Y, Zhang Z, Feng X, Zhang J,
Yuan X and Li J: Effects of shRNA-silenced livin and survivin on
lung cancer cell proliferation and apoptosis. J BUON. 19:757–762.
2014.PubMed/NCBI
|
|
24
|
Nachmias B, Ashhab Y, Bucholtz V, Drize O,
Kadouri L, Lotem M, Peretz T, Mandelboim O and Ben-Yehuda D:
Caspase-mediated cleavage converts Livin from an antiapoptotic to a
proapoptotic factor: Implications for drug-resistant melanoma.
Cancer Res. 63:6340–6349. 2003.PubMed/NCBI
|
|
25
|
Abd-Elrahman I, Hershko K, Neuman T,
Nachmias B, Perlman R and Ben-Yehuda D: The inhibitor of apoptosis
protein Livin (ML-IAP) plays a dual role in tumorigenicity. Cancer
Res. 69:5475–5480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shiloach T, Berens C, Danke C, Waiskopf O,
Perlman R and Ben-Yehuda D: tLivin displays flexibility by
promoting alternative cell death mechanisms. PLoS One.
9:e1010752014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nachmias B, Lazar I, Elmalech M,
Abed-El-Rahaman I, Asshab Y, Mandelboim O, Perlman R and Ben-Yehuda
D: Subcellular localization determines the delicate balance between
the anti- and pro-apoptotic activity of Livin. Apoptosis.
12:1129–1142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kafri T, Blömer U, Peterson DA, Gage FH
and Verma IM: Sustained expression of genes delivered directly into
liver and muscle by lentiviral vectors. Nat Genet. 17:314–317.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Piacibello W, Bruno S, Sanavio F, Droetto
S, Gunetti M, Ailles L, Santoni de Sio F, Viale A, Gammaitoni L,
Lombardo A, et al: Lentiviral gene transfer and ex vivo expansion
of human primitive stem cells capable of primary, secondary, and
tertiary multi-lineage repopulation in NOD/SCID mice. Nonobese
diabetic/severe combined immunodeficient. Blood. 100:4391–4400.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tabatabai G, Hasenbach K, Herrmann C,
Maurer G, Möhle R, Marini P, Grez M, Wick W and Weller M: Glioma
tropism of lentivirally transduced hematopoietic progenitor cells.
Int J Oncol. 36:1409–1417. 2010.PubMed/NCBI
|
|
31
|
Goel HL and Mercurio AM: VEGF targets the
tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee S, Chen TT, Barber CL, Jordan MC,
Murdock J, Desai S, Ferrara N, Nagy A, Roos KP and Iruela-Arispe
ML: Autocrine VEGF signaling is required for vascular homeostasis.
Cell. 130:691–703. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Overall CM and Kleifeld O: Tumour
microenvironment -opinion: Validating matrix metalloproteinases as
drug targets and anti-targets for cancer therapy. Nat Rev Cancer.
6:227–239. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Overall CM and López-Otín C: Strategies
for MMP inhibition in cancer: Innovations for the post-trial era.
Nat Rev Cancer. 2:657–672. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shiau AL, Teo ML, Chen SY, Wang CR, Hsieh
JL, Chang MY, Chang CJ, Chao J, Chao L, Wu CL, et al: Inhibition of
experimental lung metastasis by systemic lentiviral delivery of
kallistatin. BMC Cancer. 10:2452010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang Z, Yoon Y, Votaw J, Goodman MM,
Williams L and Shim H: Silencing of CXCR4 blocks breast cancer
metastasis. Cancer Res. 65:967–971. 2005.PubMed/NCBI
|
|
37
|
Hartman ML and Czyz M: Anti-apoptotic
proteins on guard of melanoma cell survival. Cancer Lett.
331:24–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rashidi B, Moossa AR and Hoffman RM:
Specific route mapping visualized with GFP of single-file streaming
contralateral and systemic metastasis of Lewis lung carcinoma cells
beginning within hours of orthotopic implantation [correction of
implantion]. J Cell Biochem. 114:1738–1743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamamoto N, Tsuchiya H and Hoffman RM:
Tumor imaging with multicolor fluorescent protein expression. Int J
Clin Oncol. 16:84–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li X, Wang J, An Z, Yang M, Baranov E,
Jiang P, Sun F, Moossa AR and Hoffman RM: Optically imageable
metastatic model of human breast cancer. Clin Exp Metastasis.
19:347–350. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li W, Li H, Li J, Wang H, Zhao H, Zhang L,
Xia Y, Ye Z, Gao J, Dai J, et al: Self-assembled supramolecular
nano vesicles for safe and highly efficient gene delivery to solid
tumors. Int J Nanomed. 7:4661–4677. 2012. View Article : Google Scholar
|
|
42
|
Cool SK, Breyne K, Meyer E, De Smedt SC
and Sanders NN: Comparison of in vivo optical systems for
bioluminescence and fluorescence imaging. J Fluoresc. 23:909–920.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Burrell-Saward H, Rodgers J, Bradley B,
Croft SL and Ward TH: A sensitive and reproducible in vivo imaging
mouse model for evaluation of drugs against late-stage human
African trypanosomiasis. J Antimicrob Chemother. 70:510–517. 2015.
View Article : Google Scholar
|
|
44
|
Liu HS, Jan MS, Chou CK, Chen PH and Ke
NJ: Is green fluorescent protein toxic to the living cells? Biochem
Biophys Res Commun. 260:712–717. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ejeskär K, Fransson S, Zaibak F and
Ioannou PA: Method for efficient transfection of in
vitro-transcribed mRNA into SK-N-AS and HEK293 cells: Difference in
the toxicity of nuclear EGFP compared to cytoplasmic EGFP. Int J
Mol Med. 17:1011–1016. 2006.PubMed/NCBI
|
